Quick Answer
Raphael Pharmaceutical Inc. reported Shares Outstanding of 20.18 million shares for fiscal year 2025.
Raphael Pharmaceutical Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 20.18M | +7.9% |
| 2024 | 18.70M | +1.1% |
| 2023 | 18.50M | +18.4% |
| 2022 | 15.62M | +20.5% |
| 2021 | 12.97M | +12970440.0% |
| 2021 | 100 | -100.0% |
| 2020 | 9.46M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 19.63M | +4.9% | +0.0% |
| June 30, 2025 | 19.63M | +4.9% | +0.0% |
| March 31, 2025 | 19.63M | +5.2% | +4.9% |
| December 31, 2024 | 18.70M | +1.1% | +0.0% |
| September 30, 2024 | 18.70M | +3.3% | +0.0% |
| June 30, 2024 | 18.70M | +14.3% | +0.2% |
| March 31, 2024 | 18.66M | +16.6% | +0.9% |
| December 31, 2023 | 18.50M | +18.4% | +2.2% |
- Raphael Pharmaceutical Inc. showed an increase of +7.9% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Raphael Pharmaceutical Inc.’s shares outstanding has grown by 113.3% (from 9.46 million shares to 20.18 million shares).
- The most recent figure is from Raphael Pharmaceutical Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: